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Abstract
Objective To document age- and sex-related differences in
the 16 phenotypes of risk factors for the metabolic syn-
drome (MS) among adults in the Fels Longitudinal Study
(FLS).
Methods Data on risk factors for the MS were analyzed in
471 white men and 503 white women in the FLS. We used
the Cochran-Armitage test to compare age- and sex-related
differences in the prevalence of the 16 diagnostic clusters of
positive risk factors.
Results Of the 974 subjects, 238 were found to meet diag-
nostic criteria for 15 of a possible 16 phenotypes of the MS.
The prevalence of the MS was four times greater in subjects
older than 40 years than in subjects 20–40 years old. Older
subjects had more risk factors exceeding criterion values
than younger subjects. Among those who met three-to-five
criteria for the MS, younger subjects were more likely to
have dyslipidemia, less likely to have high blood pressure
(HBP), and two times less likely to have impaired fasting
plasma glucose (IFG) than subjects 40+ years old. Older
men were more likely than older women to have HBP and
IFG. . We found that if one of the five risk factors reaches a
criterion value, the values for the other four risk factors
move closer to their own diagnostic criterion values in
apparent synchrony.
Conclusions Subjects 40+ years old are four times likelier
to have the MS than younger subjects, and older men are at
higher risk than older women. The mean values for each of
the five risk factors get progressively worse as the number
of risk factors meeting diagnostic criteria increases. There-
fore, when one factor is found to meet its diagnostic crite-
rion, levels of the other four risk factors should be measured.
The different phenotypic patterns that comprise the MS
should prompt clinicians to target specific risk factors for
prevention or treatment. Certain phenotypes were found
more commonly in women and certain others more com-
monly in men. Similarly, certain phenotypes were found
more commonly in older than in younger age groups. These
age- and sex-specific phenotypes should help clinicians to
identify subjects at highest risk for certain risk factors and to
initiate specifically tailored preventive and therapeutic inter-
ventions. Our observations should also stimulate clinical
investigators and epidemiologists to ascertain what factors
determine the sex and age specificity of certain phenotypes
of the MS.
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Introduction
The Third Report of the National Cholesterol Education
Program (NCEP) Adult Treatment Panel III (ATP III) on
Detection, Evaluation, and Treatment of High Blood Cho-
lesterol in Adults provides a working definition of the MS
(Adult Treatment Panel III 2001). The ATP III defines the
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MS as a cluster of three, four, or five risk factors that exceed
criterion values, namely: waist circumference >102 cm for
men and >88 cm for women; systolic blood pressure ≥130
and/or diastolic blood pressure ≥85 mm Hg; fasting plasma
triglyceride level ≥150 mg/dl; fasting plasma HDL-cholesterol
level <40 mg/dl for men and <50 mg/dl for women; and
fasting plasma glucose concentration >100 mg/dl.
Using the NCEP ATP III criteria, Ford et al. (2002)
reported that approximately 24% of US adults have the
MS and that its prevalence is age-dependent and sexually
dimorphic. The prevalence of the MS increases from 7% in
the third decade to 44% in the seventh decade. While the
overall prevalence differs little between men (24%) and
women (23%), the frequency distribution of risk factors that
contribute to the metabolic syndrome differs greatly be-
tween men and women. Women are more likely than men
to meet the criteria for abdominal obesity and low levels of
fasting HDL-cholesterol, while men are more likely than
women to meet the criteria for hypertriglyceridemia, HBP
and IFG (Ford et al. 2002; Park et al. 2004).
The MS comprises 16 possible clusters of the five diag-
nostic risk factors taken in combinations of three, four or
five. In the Fels Longitudinal Study (FLS) data, several of
the 16 clusters are more common than others. Information
on the prevalence by age and sex of the 16 clusters of risk
factors that define the syndrome may elucidate the origins of
the MS and may sharpen predictions for the metabolic and
cardiovascular consequences of the MS. This information
may lead to improvements in the clinical management of
patients who meet one or two but not three of the ATP III
diagnostic criteria for the MS.
We analyzed data from the FLS to examine age- and sex-
related differences in the frequency distribution of the 16
possible clusters of three or more of the five risk factors that
define the MS. We conducted the study using both the
NCEP ATP III criterion of 110 mg/dl and the ADA recom-
mended criterion of 100 mg/dl for impaired fasting plasma
glucose in order to elucidate the diagnostic implications of
the lower threshold (Genuth et al. 2003).
Subjects and methods
Study sample
The study sample consists of 471 white men and 503 white
women participants in the FLS. Initiated in 1929, the FLS is
the world’s largest and oldest longitudinal study of human
growth and body composition (Roche 1992). Approximately
8% of FLS participants have been lost to follow-up over the
eight decades of observation and 16% have died, but their
body composition and cardiovascular data at their last visit did
not differ from those who remain active in the study.
Childhood measurements made on FLS participants from
birth include weight, height, skinfold thicknesses, arm, head
and waist circumferences, and blood pressure. These data are
recorded during regular examinations at 1, 3, 6, 9, and
12 months, then semi-annually to 18 years, and biennially
thereafter. In 1976 examinations of body composition by
hydrodensitometry were included, as well as determinations
of fasting plasma lipids, lipoproteins, glucose, and insulin
concentrations when the participants turned 8 years of age.
In this study of 974 FLS participants, data were analyzed
on waist circumference, systolic blood pressure, and levels
of fasting plasma HDL-cholesterol, triglycerides, and glu-
cose. Waist circumference was measured using standardized
procedures similar to those recommended at the Airlie Con-
sensus Conference (Lohman et al. 1988). Blood pressure
was measured according to the standards of the Second
NHLBI Task Force on Blood Pressure Control in Children
and the update of that report by the National High Blood
Pressure Education Program (Falkner et al. 1996). Fasting
plasma levels of triglycerides, HDL-cholesterol and total
cholesterol were measured (NHLBI 1974) at the Medical
Research Laboratory in Cincinnati, OH. Measurements of
fasting plasma glucose and insulin concentrations were also
performed at the Medical Research Laboratory using a stan-
dard insulin radioimmunoassay (Linco Research, St. Louis,
MO) and a standard colorimetric method for measurement
of plasma glucose. All procedures were approved by the
Institutional Review Boards of Virginia Commonwealth
University and Wright State University.
Statistical analysis
The prevalence of the MS was determined for men and
women in two age groups: 20–40 years and greater than
40 years. The prevalences of zero, one or two risk factors
exceeding criteria were also ascertained for comparative
analysis. Since the diagnosis of the MS requires that at least
three of five risk factors exceed criterion values, it is possi-
ble to have 10 diagnostic combinations of three risk factors,
five diagnostic combinations of four risk factors, and one
combination of all five risk factors. The frequency distribu-
tions of the 16 combinations of risk factors that define the
MS were computed separately for both sexes and both age
groups. In order to assess the degree of deviation from non-
diagnostic values, means and standard deviations for the
five risk factors were compared between adults with the
MS and adults with zero, one, or two risk factors that
exceeded diagnostic criteria. The effects of age and gender
on the risk factor(s) of the MS were assessed using an
analysis of variance (ANOVA) model with fixed effects
for age, gender, and age-by-gender interaction. The
Cochran-Armitage trend test was applied to compare age-
and gender-related differences in the prevalence of the MS
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and the 16 possible diagnostic clusters of risk factors. Anal-
yses were performed using the Statistical Analysis System
(SAS Version 9.2 SAS Institute).
Results
Sample characteristics
We found significant age and sex differences in the mean
values of the five risk factors for the MS (Table 1). In
general, the age-related difference in mean values for the
risk factors increases with the number of risk factors meet-
ing the ATP III diagnostic criteria for the MS. Figures 1 and
2 show that within both age groups the mean value for each
risk factor approaches the diagnostic criterion value for that
risk factor in direct proportion to the number of risk factors
that meet diagnostic criteria, from zero to three or more. For
instance, if one of the five risk factors reaches a diagnostic
criterion value, the mean values for each of the other four
risk factors move closer to their respective diagnostic crite-
rion values in apparent synchrony, and if two risk factors
Table 1 Means and standard deviations (SD) of values for risk factors for metabolic syndrome in FLS subjects according to number of risk factors
that exceed ATP III diagnostic criteria
Zero risk factors One risk factors Two risk factors 3+ riskfactors
N Mean SD N Mean SD N Mean SD N Mean SD
Men 20–40 years
Age (years) 231 28 4.3 81 29 4.4 47 29 4.8 33 30 4.4
Waist circumference (cm) 164 85**, **** 7.1 73 94**, **** 13.3 47 99*, *** 14.2 33 112*** 14.7
Systolic blood pressure (mmHg) 231 113**** 7.5 81 118**** 9.9 47 120** **** 10.5 33 125**, g 9.5
HDL-cholesterol (mg/dl) 151 52**, **** 8.5 70 45**, **** 10.2 45 42*** 9.7 33 36**, **** 5.3
Triglyceride (mg/dl) 151 91**** 28.4 70 132**** 69.9 45 211*, **** 183.8 33 271*, *** 161.3
Glucose concentration (mg/dl) 108 87**, **** 7.4 58 89*, *** 7.9 40 94*, **** 8.5 31 96* 11.0
Men 40+ years
Age (years) 75 51 7.0 61 52 10.0 64 54 8.7 102 53 9.1
Waist circumference (cm) 75 92**, **** 6.4 59 98**, ** 9.0 64 105*, *** 9.7 102 112*** 11.2
Systolic blood pressure (mmHg) 75 114**** 8.1 61 121*** 14.2 64 129** 13.2 102 131**, *** 11.1
HDL-cholesterol (mg/dl) 69 56**, **** 11.0 58 52**, **** 11.8 64 45**** 8.7 102 40**, **** 6.8
Triglyceride (mg/dl) 69 94**** 27.2 58 127**** 51.1 64 160* 72.8 102 215* 85.1
Glucose concentration (mg/dl) 71 88*, **** 5.8 58 91*, *** 9.6 64 99*, **** 19.8 99 107* 21.3
Women 20–40 years
Age (years) 242 29 4.1 123 29 4.7 36 30 4.9 23 30 5.4
Waist circumference (cm) 162 78*, **** 4.9 121 89**, **** 11.2 36 97*, *** 11.8 23 105*** 11.1
Systolic blood pressure (mmHg) 241 103** **** 7.2 122 107**, **** 8.8 36 109** **** 8.8 23 117**, *** 11.6
HDL-cholesterol (mg/dl) 149 63**,**** 10.0 118 54**, **** 10.5 36 47**, *** 7.1 23 39**, **** 6.4
Triglyceride (mg/dl) 149 82**** 24.2 118 93*** 34.5 36 129** 65.6 23 199*** 66.7
Glucose Concentration (mg/dl) 118 83**, **** 8.1 93 86*, *** 11.6 27 86*, **** 6.4 23 97* 25.6
Women 40+ years
Age (years) 92 51 7.3 101 51 8.4 62 55 10.8 80 54 10.0
Waist circumference (cm) 92 80**, **** 5.0 101 94**, **** 10.5 62 98*, *** 12.6 80 105*** 13.0
Systolic blood pressure (mmHg) 92 109** **** 9.5 101 115**, *** 14.5 62 127** 15.6 80 127**, g 13.7
HDL-cholesterol (mg/dl) 87 69**, **** 12.0 99 61**, **** 10.9 58 57**, ** 12.5 80 46**, **** 9.1
Triglyceride (mg/dl) 87 88**** 24.2 99 107**** 32.7 58 137 41.1 80 213 78.6
Glucose Concentration (mg/dl) 89 85*, **** 6.2 99 89*, *** 6.1 60 91*, **** 10.0 80 106* 29.0
Note: The statistical analysis was based on with fixed effects for age group, gender, and age group-by-gender interaction for each metabolic
syndrome risk factor
*Significant age different p<0.05
**Significant age different p<0.001
***Significant gender different p<0.05
****Significant gender different p<0.001
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reach their diagnostic criterion values, the mean values for
the other three risk factors move even closer to their respec-
tive diagnostic criterion values, again in apparent synchro-
ny. This effect is most pronounced for the elevated fasting
plasma triglycerides.
Clustering of components of the MS
Younger vs. older subjects
The prevalence of the MS was four times as great among the
older vs. the younger age groups (p<0.0001). Among both
men and women, there is a significant difference in the
prevalence of MS between age groups—p<0.0001 (Table 2;
Fig. 3). Older subjects tended to be more obese, dyslipi-
demic, and hypertensive than younger ones (Table 1). Men
and women older than 40 years with the MS also had a
significantly greater number of risk factors that exceed
diagnostic criterion values than men and women 20–40 years
old, according to the Cochrane-Armitage Trend Test (p<
0.05 (Table 2). Overall, the men had a prevalence of the MS
50% greater than the women (p00.0025); however, when
analyzed by age group, the prevalence differs significantly
between men and women in the older (p00.0058) but not
the younger age group—p00.091 (Table 2; Fig. 3).
Subjects meeting three criteria for the MS
Among 20–40 year-old subjects with the MS, 76% of the
women and 52% of the men met criteria for the diagnostic
triad of increased waist circumference, low level of fasting
plasma HDL-cholesterol, and elevated level of fasting plas-
ma triglycerides (Table 3; Fig. 4). Among subjects older
than 40 years with the MS, 48% of women met criteria for
the same diagnostic triad compared to 13% of men (Table 3;
Fig. 5). The smaller percentages of older women and men
who met criteria for this triad compared to younger women
and men may be explained by the greater numbers of older
women and men meeting diagnostic criteria for eight of the
other nine diagnostic triads. For example, men 20–40 years
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diagnostic triads, whereas men older than 40 years with three
positive risk factors met criteria for nine of the 10 diagnostic
triads. Women 20–40 years old with the MS met criteria for
only four of the 10 diagnostic triads, while women older than
40 years with three positive risk factors met criteria for seven
of the 10 diagnostic triads (Table 3). It is interesting to note
that the risk factors for the MS cluster both with and without
increased waist circumference. This observation indicates that
the clusters of risk factors that define the MS are not neces-
sarily driven by centripetal obesity.
Subjects meeting two criteria for the MS
Subjects who meet two criteria for a diagnosis of the MS
are, presumably, at greater risk for meeting three or more
diagnostic criteria than subjects who meet zero criteria.
Therefore, we analyzed the frequency distribution of the
five risk factors in subjects meeting two criteria accord-
ing to age and sex. There are 10 combinations of any
two of the five risk factors that meet criteria for the
MS. Women 20–40 years old met criteria for five of the
10 possible dyads, whereas women older than 40 years
met criteria for eight of the ten dyads (Table 4). Men
20–40 years old met criteria for nine of the 10 dyads,
and men older than 40 years met criteria for all ten.
Among 47 men between 20 and 40 years old who met
two, but not more, criterion values, the most prevalent
dyad, was a low level of fasting plasma HDL-cholesterol and
an elevated level of fasting plasma triglycerides found
in 32% of these men. Among the 64 men older than
Table 2 Numbers and prevalence* of FLS subjects whose risk factor values exceed ATP III criteria for zero to five risk factors
20–40 years 40+ years
Men Women Men Women
Non-metabolic syndrome**, *** 359 (92%)** 401 (95%)** 200 (66%)**, *** 255 (76%)**, ***
Zero risk factors 231 (59%) 242 (57%) 75 (25%) 92 (27%)
One risk factor 81 (21%) 123 (29%) 61 (20%) 101 (30%)
Two risk factors 47 (12%) 36 (8%) 64 (21%) 62 (19%)
Metabolic syndrome**, *** 33 (8%)** 23 (5%)** 102 (34%)**, *** 80 (24%)**, ***
Three risk factors 23 (6%) 17 (4%) 56 (19%) 46 (14%)
Four risk factors 8 (2%) 5 (1%) 33 (11%) 25 (7%)
Five risk factors 2 (1%) 1 (0%) 13 (4%) 9 (3%)
Note 1: Prevalence: Number of subjects in each age-by-sex-by risk factor category divided by the total number of subjects in each column,
expressed as a percentage
Note 2: Cochran-Armitage trend test was used to analyze the underlying trend between age groups and gender
* Significant age different p<0.05
** Significant age different p<0.001
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40 years, the most prevalent dyad, found in 33% of
them, was increased waist circumference and HBP (Table 4).
Among the 36 women between the ages of 20 and 40 years
who met two criteria, the dyad of increased waist circumfer-
ence and low level of fasting plasma HDL-cholesterol was the
most prevalent, found in 64% of these women. Three dyads
with increased waist circumference accounted for 80% of the
dyads that met criterion values, one coupled with HBP; one
coupled with increased fasting plasma triglycerides; and one
coupled with a low level of fasting plasma HDL-cholesterol.
These dyads were found in 31, 24, and 23%, respectively, of
the women over 40 years with two positive risk factors.
(Table 4).
Subjects meeting one criterion for the MS
Among the eighty-one 20–40-year-old men with only a
single risk factor meeting a diagnostic criterion, a low level
of fasting plasma HDL-cholesterol was found in 27% of
them and an elevated level of fasting plasma triglycerides
was found in 26%. IFG, found in 6% of these men, was the
least prevalent single risk factor meeting a criterion value.
Among men older than 40 years meeting a single diagnostic
criterion value, HBP, found in 31% of them, was the most
prevalent, followed by increased waist circumference, found
in 25% of these men, and by elevated fasting plasma trigly-
cerides, found in 23% of them (Table 4).
Table 3 Numbers and propor-
tions (%) of clusters of risk fac-
tors diagnostic of metabolic
syndrome in FLS subjects by
age group and sex
WC waist circumference; SBP
systolic blood pressure; HDL
fasting plasma high density li-
poprotein cholesterol; TG fasting
plasma triglycerides; GLU im-
paired fasting plasma glucose
concentration
20–40 years 40+ years
Men Women Men Women
Three risk factors
WC, BP, HDL 2 (9%) 2 (12%) 3 (5%) 2 (4%)
WC, BP, TG 2 (9%) 15 (27%) 7 (15%)
WC, BP, GLU 7 (13%) 4 (9%)
WC, TG, GLU 1 (4%) 1 (6%) 7 (13%) 4 (9%)
WC, HDL, TG 12 (52%) 13 (76%) 7 (13%) 22 (48%)
WC, HDL, GLU 1 (4%) 1 (6%) 5 (9%) 5 (11%)
BP, HDL, TG 2 (9%) 6 (11%) 2 (4%)
BP, TG, GLU 3 (5%)
HDL, TG, GLU 3 (13%) 3 (5%)
HDL, BP, GLU
Total 23 17 56 46
Four risk factors
WC, BP, HDL,TG 6 (75%) 2 (40%) 12 (36%) 8 (32%)
WC, BP, HDL, GLU 1 (20%) 3 (9%) 3 (12%)
WC, BP, TG, GLU 6 (18%) 3 (12%)
WC, HDL, TG, GLU 1 (13%) 2 (40%) 11 (33%) 11 (44%)
BP, HDL, TG, GLU 1 (13%) 1 (3%)
Total 8 5 33 25
Five risk factors
WC, BP, HDL, TG, GLU 2 1 13 9

























Fig. 4 Triad phenotypes of
metabolic syndrome in FLS
participants 20–40 years of age
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Increased waist circumference was the most prevalent
single risk factor meeting a criterion value in both the 123
younger and the 101 older women, found in 50 and 73%,
respectively. We also found that low HDL-cholesterol was
the single positive risk factor in 37% of women younger
than 40 years with one positive risk factor for the MS.
Differences in risk factor prevalence according to sex
Among subjects older than 40 years, men had a significantly
higher prevalence of the MS (34%) than women (24%; p<
0.05; Table 2). This finding differs from that of Ford et al.
(2004) who found a similar prevalence in men and women.
However, this sex-associated difference was not found in
subjects 20–40 years old, among whom 8% of the men and
5% of the women met criteria for a diagnosis of the MS.
Among women of both age groups, and among 20–40-
year-old men, the most commonly encountered diagnostic
triad consisted of increased waist circumference, low levels
of fasting plasma HDL-cholesterol, and elevated levels of
fasting plasma triglycerides (Table 3). This diagnostic triad




































Fig. 5 Triad phenotypes of metabolic syndrome in FLS participants 40+ years of age
Table 4 Numbers and propor-
tions (%) of zero, one, or com-
binations of two risk factors
exceeding ATP III criteria for
metabolic syndrome in FLS
subjects adults 20 years and
older by age group and sex
WC waist circumference; SBP
systolic blood pressure; HDL
fasting plasma high density li-
poprotein cholesterol; TG fasting
plasma triglycerides; GLU im-
paired fasting plasma glucose
concentration
20–40 years 40+ years
Men Women Men Women
Two risk factors
WC, BP 7 (15%) 1 (3%) 21 (33%) 19 (31%)
WC, TG 7 (15%) 5 (14%) 7 (11%) 15 (24%)
WC, HDL 4 (9%) 23 (64%) 3 (5%) 14 (23%)
WC, GLU 2 (4%) 1 (3%) 7 (11%) 5 (8%)
BP, HDL 2 (3%) 4 (6%)
BP, TG 3 (6%) 6 (9%) 3 (5%)
BP, GLU 1 (2%) 5 (8%) 1 (2%)
HDL, TG 15 (32%) 6 (17%) 7 (11%)
HDL, GLU 3 (6%) 1 (2%)
TG, GLU 5 (11%) 5 (8%) 1 (2%)
Total 47 36 64 62
One risk factor
WC 17 (21%) 62 (50%) 15 (25%) 74 (73%)
BP 16 (20%) 3 (2%) 19 (31%) 9 (9%)
HDL 22 (27%) 45 (37%) 4 (7%) 9 (9%)
TG 21 (26%) 9 (7%) 14 (23%) 8 (8%)
GLU 5 (6%) 4 (3%) 9 (15%) 1 (1%)
Total 81 123 61 101
Zero risk factors 231 242 75 92
Total number of adults without metabolic syndrome 359 401 200 255
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of the women older than 40 years who had the MS and was
also found in 52% of the men 20–40 years old with the MS.
The triads that included increased waist circumference
accounted for the diagnosis of the MS in 79% of men older
than 40 years.
The prevalence of the 16 possible phenotypes of the MS
varied markedly by sex. No single phenotype predominated
in the men, whereas nearly one-half of the women had
dyslipidemia with increased waist circumference. Among
subjects with the MS older than 40 years, women were 3.5
times as likely to have increased waist circumference with
dyslipidemia as men.
IFG was the least commonly encountered positive risk
factor. Among subjects in the 20–40-year-old age group
who met three or more diagnostic criteria for the MS, nine
of 33 men and six of 23 women had IFG. Among older
subjects who met three or more diagnostic criteria for the
MS, 59 of 102 men and 39 of 80 women had IFG. In
younger subjects, two of the six possible triads that include
IFG, were identified in women, and three in men. The
diagnostic triad of IFG, HBP, and low level of fasting
plasma HDL-cholesterol was met by none of the men or
women in either age groups, and is the only one of the ten
possible diagnostic triads not satisfied by any of the 142
subjects who met only three of the five criteria for a diag-
nosis of the MS. Of the 71 subjects who met four of the five
criteria, the cluster of IFG, HBP and low HDL-cholesterol
was found in only nine of them.
The distributions of the ten dyads for any two of the five
risk factors that met diagnostic criteria for MS differed
significantly between men and women (Fig. 2; Table 4).
Of the 20–40 year old subjects with two risk factors that
met criteria for the MS, 32% of the men but only 17% of the
women had elevated levels of fasting plasma triglycerides
and low levels of fasting plasma HDL-cholesterol, while 9%
of the men, but 64% of the women in this age group, had
increased waist circumference and low levels of fasting
plasma HDL cholesterol. Among subjects older than
40 years with two positive risk factors, 33% of the men
and 31% of the women had increased waist circumference
and HBP. IFG was the least likely condition to be encoun-
tered in both sexes and in both age groups. Among the 209
subjects in both age groups who met only two diagnostic
criteria, 29 of the 111 men and 8 of the 98 women had
fasting plasma glucose levels that exceeded the ADA crite-
rion value of 100 mg/dl (Table 4).
Among the subjects with just one risk factor that
exceeded a criterion value, there are several notable differ-
ences. In 20–40 year old subjects, men were more nearly
four times more likely than women to have increased trigly-
cerides (26 vs. 7%) and ten times more likely that women to
have HBP (20 vs. 2%). On the other hand women were more
than twice as likely as men to have increased waist
circumference (50 vs. 21%) and 1.4 times as likely to have
low HDL-cholesterol (37 vs. 27%).
In subjects over 40 years with just one positive risk
factor, the men were three times more likely than the women
to have high fasting plasma triglycerides (23 vs. 8%) or
HPB (31 vs. 9%), whereas the women were nearly three
times more likely than the men to have increased waist
circumference (73 vs. 25%).
Discussion
Reaven (1988) reported a clustering of dyslipidemia, hyper-
tension, and glucose intolerance which he named syndrome
X. The NCEP ATP III expanded the cluster of risk factors
for the syndrome by adding waist circumference, a proxy for
visceral fat accumulation (Adult Treatment Panel III 2001).
The existence of the MS as a true syndrome rather than an
association of risk factors that co-vary with obesity has been
debated in the literature (Kahn et al. 2005; Cheng and Leiter
2006). In our present analysis of a large quantity of serial
metabolic and anthropometric data, subjects without in-
creased waist circumference who met just one or two of
the other four criterion values for the MS show the same rate
of progression toward a diagnosis of the MS as those sub-
jects with increased waist circumference (Fig. 1). This ob-
servation indicates that the risk factors for operate in concert
with or without obesity, and implies the existence of a true
syndrome that is not simply a collection of covariates driven
by obesity.
We found that the prevalence of the MS in both men and
women older than 40 years is four times that in 20–40 year-
old-subjects. Meigs et al. (2003) also reported substantial
age differences in the prevalence of the MS. Among sub-
jects older than 40 years, we found that 24% of the women
and 34% of the men met criteria for a diagnosis of the MS.
The 34% prevalence that we observed among the men is
greater than the 24% reported by Ford et al. (2002). This
discrepancy may reflect the difference between men in the
FLS who reside predominantly in southwestern Ohio and
men in the NHANES US population-based sample studied
by Ford et al. (2002).
Our analysis also shows that several of the five risk
factors for the MS cluster together as a phenotype more
often than others and are the main contributors to the high
prevalence of the syndrome. The two most commonly en-
countered diagnostic triads in the FLS population include
increased waist circumference and high fasting plasma tri-
glycerides, coupled with either low fasting plasma HDL-
cholesterol or HBP. We found that the frequency distribu-
tions of the clusters of risk factors that define the MS depend
on both age and sex (Figs. 4 and 5). Older subjects had a
greater number of risk factors that exceed criterion values
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than younger adults among both the men and the women,
and older adults were six times more likely than younger
adults to meet the diagnostic criterion for HBP and five
times more likely to meet the diagnostic criterion for IFG.
Even after we lowered the diagnostic criterion for im-
paired fasting plasma glucose from 110 mg/dl (NCEP ATP
III) to 100 mg/dl (Genuth et al. 2003), this risk factor
remained the least commonly met criterion. Only 111 of
the 471 men and 58 of the 503 women in our study popu-
lation had at least one recorded value of fasting plasma
glucose >100 mg/dl. Of the six possible diagnostic triads
that include IFG, the triad of increased waist circumference,
low level of fasting plasma HDL, and IFG applied to only 6
of the 63 women in both age groups combined who met
criteria for one of the diagnostic triads. The triad of in-
creased waist circumference, HBP and IFG, and the triad
of increased waist circumference, increased level of fasting
plasma triglycerides and IFG applied to only four and five,
respectively, of the 63 women in both age groups combined
who met criteria for one of the diagnostic triads. None of the
63 women met the criteria for the remaining three diagnostic
triads that include IFG (Table 3). In contrast to the situation
among the women, at least one of the 79 men in both age
groups combined met criteria for five of the six diagnostic
triads that include IFG.
Ford et al. (2002) also found in the NHANES data set
that. IFG was the least commonly met criterion for the MS,
especially among women. The FLS data show that 59% of
the younger men and 25% of the older men did not meet the
diagnostic criteria for any of the five risk factors for the MS.
This age dimorphism is also seen in women, among whom
57% of the young women and 27% of the older women did
not meet any of the five criteria. It appears that the factors in
young women that offer protection against the onset of the
MS wane in influence after age 40 years, perhaps reflecting
the onset of menopause. In women of both age groups, waist
circumference was the risk factor that most frequently
exceeded its ATP III criterion value. In sharp contrast, blood
pressure was the risk factor that most frequently exceeded
its criterion value in older men and, among younger men,
the level of fasting plasma HDL-cholesterol was the risk
factor that most frequently exceeded its criterion value.
In view of the age-related and sex-related heterogeneity
of the 16 clusters of risk factors that define the MS, it would
appear to be clinically important to become aware of the
most prevalent clusters of risk factors for the MS in younger
and older men and women. We found that the clusters of risk
factors that define the MS differ markedly by sex (Figs. 4
and 5). This phenotypic sexual dimorphism may reflect
genetic and/or hormonal influences on adipose tissue, lipid
metabolism, glucose metabolism, and blood pressure.
Identification of the onset of the atherogenic profile in men
and women according to age is a significant contribution of
our analysis of serial data in 974 subjects in the FLS. Identi-
fication of the dyad of decreased HDL-cholesterol and in-
creased triglycerides and of the triad that includes diagnostic
values for these two risk factors along with HBP in any decade
of life, but especially in earlier decades, would appear to be
important in regard to predicting the onset of atherosclerotic
cardiovascular disease and prescribing preventive regimens.
Family history also affects components of the MS. Arya
et al. (2002) reported genetic susceptibility to the MS in
Mexican Americans. Data from the Bogalusa Heart Study
(BHS) indicate that offspring of parents with coronary artery
disease develop excess body fat in childhood and manifest
hyperinsulinemia in young adulthood. Other data from the
BHS show that clusters of three, four or five risk factors are
more likely than would be expected by chance to be
inherited by offspring from their parents than one or two
risk factors (Berenson and Srinivasan 2001). This covari-
ance of the five risk factors is also salient in our data.
Figure 1 shows that within both age groups the values for
each of the five risk factors approaches its diagnostic crite-
rion in direct proportion to the number of risk factors meet-
ing diagnostic criteria, from zero to three or more. This
observation supports the concept that the MS is a single
physiologic entity rather than a collection of independent
risk factors.
The 16 different phenotypes of the MS may carry differ-
ent prognostic implications in regard to the development of
type 2 diabetes and cardiovascular disease. For example,
phenotypes that include HBP, IFG, and low fasting plasma
HDL-cholesterol may have worse prognostic implications
than those that include increased waist circumference, ele-
vated fasting plasma triglycerides and low fasting plasma
HDL-cholesterol. A priori, it would appear that men and
women who met diagnostic criteria for the MS in their third
or fourth decade are at greater risk of developing type 2
diabetes or cardiovascular disease later in life than those
who failed to meet diagnostic criteria until their fifth or sixth
decade.
Our findings will remind clinicians that there are 16
different sets of criteria that trigger the diagnosis of the
metabolic syndrome and, therefore, 16 phenotypes are all
recognized as the metabolic syndrome. This will be of
interest to clinicians who may not have thought about the
number of ways five risk factors can be combined into sets
of three, four or five and who may not have realized the
extent of the clinical variety that exists within the metabolic
syndrome.
Since the 16 phenotypes differ markedly in prevalence by
age and sex, they may call for different diagnostic and
management strategies. Emphasizing age-specific and sex-
specific phenotypes should help clinicians identify subjects
at highest risk for certain risk factors according to age and
sex. We found that the prevalence of the MS was four times
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greater in the older than in the younger age group. Men and
women older than 40 years with the MS also had a signif-
icantly greater number of risk factors that exceed diagnostic
criterion values than men and women with the MS who are
20–40 years old.
Our analyses are, based on long-term serial observations
and should improve the clinical management of obese
patients who may or may not also have dyslipidemia, or
who may or may not have HBP, and who may or may not
have IFG. Our observations should also stimulate clinical
investigators and epidemiologists to ascertain what factors
determine the striking sex- and age-specificity of the MS
phenotypes. Another observation of our study is that the risk
factors for the metabolic syndrome cluster together in the
absence of increased waist circumference as well as in its
presence, indicating that obesity is not the only driver of the
metabolic syndrome. Results of our study will provide a
basis for therapeutic and preventive strategies to interrupt
the pathophysiologic pathway leading to the metabolic syn-
drome in subjects who advance from meeting none of the
criteria for the metabolic syndrome to meeting one or more
criteria. In this regard, a sentinel finding of our study is that
when one of the five risk factors meets its criterion value,
the other four risk factors move in concert closer toward
their own criterion values. This phenomenon is also ob-
served when increased waist circumference, a proxy for
visceral obesity, is removed from the set of five risk factors.
These findings will be of interest to those who follow the
literature on the metabolic syndrome because the findings
imply that the metabolic syndrome is a true syndromic
entity, rather than groups of risk factors that co-vary with
obesity.
Our study provides clinicians and investigators with in-
triguing observations that will sharpen their clinical acumen
and should stimulate further research. For example, not one of
the 238 subjects with the metabolic syndrome exhibited the
diagnostic triad of hypertension, impaired fasting plasma glu-
cose, and low HDL-cholesterol. Therefore, clinicians need not
spend time hunting for that particular elusive set of positive
risk factors. However, investigators should be keen to discov-
er why this singular set of risk factors is so rare.
At the other extreme of the spectrum of prevalence, 54 of
the 238 subjects diagnosed with the metabolic syndrome fit
the phenotype of increased waist circumference, low HDL-
cholesterol, and hypertriglyceridemia. This prevalent pheno-
type should spring to mind when one risk factor of the triad is
found to be positive. Clinical investigators should also be
interested in finding out why this particular set of three risk
factors appears so frequently, especially in the younger group
of subjects, in whom this diagnostic triad was encountered
twice as often as all of the other diagnostic triads combined.
Since the phenotypes of the MS will differ among sub-
jects who meet one of the 16 sets of three, four or five
diagnostic criteria, clinicians may need to tailor their pre-
ventive and therapeutic strategies to individual subjects who
may have phenotypes that carry different clinical implica-
tions. Our observation showing that the mean values for
each of the five risk factors get progressively worse as the
number of risk factors meeting diagnostic criteria increases
implies that subjects should be screened routinely to identify
the appearance of a single positive risk factor in order to
apply interventions to prevent progression to one of the
phenotypes of the metabolic syndrome.
Our observations underscore the diversity of the 16 com-
binations of risk factors that prompt a diagnosis of the
metabolic syndrome and highlight the complexity of the
interactions between obesity, insulin resistance, dyslipide-
mia, and hypertension. These observations should stimulate
investigators to apply hierarchical modeling and systems
analysis to elucidate the clinical implications and long-
term outcomes of the metabolic syndrome’s 16 phenotypes.
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